Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | RXRG | P48443 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29428931 | 0.84 | CA1 (0.45) | ALDH1A1TDP1TSHRHSD17B10CA2 | |
| SCHEMBL3820431 | 0.84 | CA1 (0.45) | ALDH1A1TDP1TSHRHSD17B10CA2 | |
| SCHEMBL29947741 | 0.83 | ALDH1A1 (0.44) | ALDH1A1TDP1TSHRATMCYP1A2 | |
| SCHEMBL28783314 | 0.83 | ALDH1A1 (0.44) | ALDH1A1TDP1TSHRATMCYP1A2 | |
| SCHEMBL30500977 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TDP1TSHRATMCYP1A2 | |
| SCHEMBL127278 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TDP1TSHRATMCYP1A2 | |
| SCHEMBL24198870 | 0.81 | TDP1 (0.43) | ALDH1A1TDP1TSHRATMCYP1A2 | |
| SCHEMBL18535844 | 0.81 | CASR (0.41) | ALDH1A1TDP1TSHRATMHSD17B10 | |
| SCHEMBL12163575 | 0.81 | TDP1 (0.43) | ALDH1A1TDP1TSHRATMCYP1A2 | |
| SCHEMBL6371363 | 0.81 | TDP1 (0.47) | ALDH1A1TDP1TSHRATMCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295105-A1 | PIPERIDINEDIONE DERIVATIVES | INNOCURE THERAPEUTICS, INC. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20220393117-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-12-08 | — | — | US | disclosed |
| US-11228004-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-01-18 | — | — | US | disclosed |
| CN-106165175-B | High molecular electrolyte composition and polyelectrolyte membrane, film electrode composite element and the polymer electrolyte fuel cell for using it | 东丽株式会社 | 2019-11-08 | — | — | CN | disclosed |
| CN-110325587-A | Methacrylic resin composition and application thereof | 株式会社可乐丽 | 2019-10-11 | — | — | CN | disclosed |
| US-10197914-B2 | Positive photosensitive resin composition, photo-curable dry film and method for producing the same, patterning process, and laminate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-02-05 | — | — | US | disclosed |
| US-20170255097-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, PHOTO-CURABLE DRY FILM AND METHOD FOR PRODUCING THE SAME, PATTERNING PROCESS, AND LAMINATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-09-07 | — | — | US | disclosed |
| US-20170255097-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, PHOTO-CURABLE DRY FILM AND METHOD FOR PRODUCING THE SAME, PATTERNING PROCESS, AND LAMINATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-09-07 | — | — | US | disclosed |
| CN-106165175-A | High molecular electrolyte composition and use its polyelectrolyte membrane, film electrode composite element and polymer electrolyte fuel cell | 东丽株式会社 | 2016-11-23 | — | — | CN | disclosed |
| US-20160200877-A1 | SILICONE SKELETON-CONTAINING POLYMER COMPOUND, CHEMICALLY AMPLIFIED NEGATIVE RESIST COMPOSITION, PHOTO-CURABLE DRY FILM AND METHOD FOR PRODUCING SAME, PATTERNING PROCESS, LAYERED PRODUCT, SUBSTRATE, AND SEMICONDUCTOR APPARATUS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-07-14 | — | — | US | disclosed |
| US-20110082098-A1 | NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE | UNIVERSITY OF KANSAS (US) | 2011-04-07 | — | — | US | disclosed |
| US-20100056505-A1 | Substituted Pyrazalones | BIOGEN IDEC MA INC. | 2010-03-04 | — | — | US | disclosed |
| US-20090187014-A1 | Novobiocin Analogues | UNIVERSITY OF KANSAS | 2009-07-23 | — | — | US | disclosed |
| US-20090163709-A1 | Novobiocin Analogues Having Modified Sugar Moieties | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2009-06-25 | — | — | US | disclosed |
| US-6599969-B1 | Olefin polymer is, immediately after leaving the polymerization reactor, brought in to contact with a phenol derivative such as 2,6-di-tert-butylphenol | BASELL POLYOLEFINE GMBH (DE) | 2003-07-29 | — | — | US | disclosed |
| EP-0565966-B1 | Process for the treatment of particulate olefin polymer, resulting treated particles and method for using treated particles | MONTELL NORTH AMERICA INC (US) | 1996-11-06 | — | — | EP | disclosed |
| EP-0565966-A1 | Process for the treatment of particulate olefin polymer, resulting treated particles and method for using treated particles | MONTELL NORTH AMERICA INC. (US) | 1993-10-20 | — | — | EP | disclosed |
| US-5238635-A | Polyhydric alcohol ester and mono-ester of hindered phenol derivative of propionic acid; viscosity reducing agent; molding materials | HIMONT INCORPORATED (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0347709-A1 | Phenol alkylation process | ETHYL CORPORATION (US) | 1989-12-27 | — | — | EP | disclosed |
| EP-0347710-A2 | Phenol alkylation process | ETHYL CORPORATION (US) | 1989-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220393117-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NPY1R, NPY2R, KISS1R | ALDH1A1 1485/4885TDP1 4695/4885TSHR 163/4885 |
| US-20100056505-A1 | Substituted Pyrazalones | ACVR1, ACVRL1, TGFBR1 | ALDH1A1 507/4885TDP1 4234/4885TSHR 1477/4885 |
| US-11228004-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, ICOSLG | ALDH1A1 833/4885TDP1 3946/4885TSHR 3225/4885 |
| US-20230295105-A1 | PIPERIDINEDIONE DERIVATIVES | CRBN, CUL1, PSMB10 | ALDH1A1 2741/4885TDP1 4149/4885TSHR 3860/4885 |
| US-20090163709-A1 | Novobiocin Analogues Having Modified Sugar Moieties | HSP90AB1, HSP90B1, HSP90AB2P | ALDH1A1 3407/4885TDP1 396/4885TSHR 2801/4885 |
| US-10197914-B2 | Positive photosensitive resin composition, photo-curable dry film and method for producing the same, patterning process, and laminate | SUV39H1, JMJD6, EZH1 | ALDH1A1 1140/4885TDP1 1475/4885TSHR 3955/4885 |
| US-20090187014-A1 | Novobiocin Analogues | SSB, SSBP1, BTD | ALDH1A1 4519/4885TDP1 15/4885TSHR 4355/4885 |
| US-20110082098-A1 | NOVOBIOCIN ANALOGUES AND TREATMENT OF POLYCYSTIC KIDNEY DISEASE | PKD1, PKD2, HSP90B1 | ALDH1A1 4382/4885TDP1 4253/4885TSHR 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.